Access to antibiotics as much a concern as antimicrobial resistance, says report

The article begins with an outline today's fragile antibiotic market, highlighting the supply of life-saving antibiotics is now increasingly reliant on just a handful of companies. 

The articles' takeaway headline from the Benchmark is that, while progress is happening, and some companies are stepping up, others are either maintaining course, or even backing away from the anti-infectives space. It stresses that pharmaceutical companies need to stay committed to keeping old and new antibiotics accessible, especially in low-and middle-income countries.